Chris Duffield Ph.D.
Stanford University, Department of Materials Science & Engineering
Bldg 550 Rm 551C, Stanford CA 94305-2205 chris@... (650) 725-2643

Mr. William J. Clinton
President of the United States of America
1600 Pennsylvania Ave., Washington, D.C. 20500

June 3, 2000

Dear President Clinton,

        In your last six months as President, I encourage you start a new medical initiative that will have wonderful results and happy consequences long after you and I are gone from this life. I encourage you to start an initiative to test and deploy insulin potentiation therapy (IPT) in the US and the world.

        IPT is a simple, very safe, and apparently extremely effective medical technique that uses the hormone insulin to make standard drugs work much better, in smaller doses, and usually without any side effects. IPT is a "magic gun" that makes regular drugs into "magic bullets".

        Reported results include rapid successful treatment of breast, prostate, and lung cancer without surgery, radiation, or side effects. Also five years of relief from arthritic symptoms after just two or three IPT treatments. And rapid and effective treatment of HIV/AIDS and other infectious diseases. And amazing results in treatment of cardiovascular, respiratory, and neurological diseases, too.

        I think that IPT will eventually be recognized as one of the greatest medical discoveries of all time. On the same high level as antibiotics, anesthesia, and vaccination. I call it "The second discovery of insulin". When it is deployed in the US, the benefits of health care cost savings and improved outcomes for millions of patients will be worth trillions of dollars. Perhaps hundreds of trillions worldwide.

        You and your medical advisors can read all about IPT on a large website that I have created: www.iptq.org  (I have been involved with IPT for 14 years.)

        The challenge of IPT is that, although it has an amazing track record during more than 130 doctor-years of experience over 70 years, in five countries, it is still essentially unknown. Clinical trials and laboratory research have never been done, even though IPT has been demonstrated continuously in or near the US since the 1930s. Because IPT does not fit into the usual medical mold, institutional barriers and skepticism have kept the benefits of IPT from humanity for 70 years.

        Seventy years is much too long for us to have been denied access to IPT.   Decisive action triggered by you, Mr. President, could get IPT quickly tested and rapidly deployed, especially for the AIDS epidemic in Africa, and for our cancer epidemic here at home. A broadly focused Presidential Task Force or Initiative for IPT could overcome decades of institutional inertia and medical skepticism, and bring this about by the end of this year.

        IPT is a small modification of standard medicine. Since it is not a new drug or device, it can be adopted immediately once its effectiveness is acknowledged and verified. Thus a minuscule low-risk investment in IPT research now, could have immense benefits for the US, the world, and for humanity in all time to come. Long after all the other things that you and I have done, good or bad, are forgotten, we will be remembered and thanked for this one achievement.

        Please let me know how I may be of assistance in designing and launching this Initiative.

        Sincerely,

Chris Duffield Ph.D.

Visiting Scholar
Department of Materials Science & Engineering
Stanford University